{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:16:21Z","timestamp":1780391781246,"version":"3.54.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Aga Khan University"},{"DOI":"10.13039\/501100012632","name":"Nazarbayev University","doi-asserted-by":"publisher","award":["Collaborative Research Program Grant \u2116 111024CRP2013"],"award-info":[{"award-number":["Collaborative Research Program Grant \u2116 111024CRP2013"]}],"id":[{"id":"10.13039\/501100012632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec040\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>A subset of COVID-19 disease patients suffers a severe form of the illness; however, underlying early pathophysiological mechanisms associated with the severe form of COVID-19 disease remain to be fully understood. Several studies showed the association of COVID-19 disease severity with the changes in the expression profile of various matrix metalloproteinases (MMPs) and defensins (DA). However, the link between the changes in the expression of MMPs and DA in the nasopharyngeal milieu during early phases of infection and disease severity remains poorly understood. Therefore, we performed differential gene expression analysis of MMPs and DA in the nasopharyngeal swab samples collected from normal (COVID-19 negative), mild, and severe COVID-19 cases and examined the association between MMP and DA expression and disease severity.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec041\">\n<jats:title>Material and method<\/jats:title>\n<jats:p>A total of 118 previously collected nasopharyngeal samples from mild and severe COVID-19 patients (as per the WHO criteria) and 10 healthy individuals (COVID-19 negative, controls) were used in this study. A real-time qPCR assay was used to determine the viral loads and assess the mRNA expression of MMPs and DA. One-way ANOVA was applied to perform multiple comparisons (estimate differences) in MMPs and defensin gene expression in the normal vs mild vs severe groups. In addition, a multivariable logistic regression analysis was carried out with all the variables from the data set using \u2018severity\u2019 as the outcome variable. <\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec043\">\n<jats:title>Results<\/jats:title>\n<jats:p>Our results showed that as compared to controls, DA1, DA3, and DA4 expression was significantly (p &lt; 0.05) upregulated in the mild group, whereas the expression of DA6 was significantly downregulated in both mild and severe groups (p-value &lt; 0.05). Similarly, compared to controls, the expression of MMP1 and MMP7 was significantly downregulated in both mild and severe groups, whereas MMP2 expression was upregulated in the mild group (p-value &lt; 0.05). Additionally, the regression analysis showed that the expression of MMP1, MMP2, and MMP9 was significantly associated with the severity of the disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec044\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The early detection of changes in the expression of MMPs and defensins may act as a useful biomarker\/predictor for possible severe COVID-19 disease, which may be useful in the clinical management of patients to reduce COVID-19-associated morbidity and mortality.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0304311","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:43:49Z","timestamp":1739904229000},"page":"e0304311","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of differential expression of matrix metalloproteinases and defensins in the nasopharyngeal milieu of mild and severe COVID-19 cases"],"prefix":"10.1371","volume":"20","author":[{"given":"Khekashan","family":"Imtiaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alnara","family":"Zhamalbekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Faraz","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeshan","family":"Ansar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khitab","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sarr\u00eda-Santamera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-0902","authenticated-orcid":true,"given":"Syed Hani","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"issue":"3","key":"pone.0304311.ref001","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/biom11030390","article-title":"Targeting MMP-regulation of inflammation to increase metabolic tolerance to COVID-19 pathologies: a hypothesis","volume":"11","author":"E Hardy","year":"2021","journal-title":"Biomolecules"},{"issue":"18","key":"pone.0304311.ref002","doi-asserted-by":"crossref","first-page":"eabc1518","DOI":"10.1126\/sciadv.abc1518","article-title":"Surviving COVID-19: a disease tolerance perspective","volume":"6","author":"JS Ayres","year":"2020","journal-title":"Sci Adv"},{"issue":"7","key":"pone.0304311.ref003","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-020-0237-2","article-title":"Metabolic handbook for the COVID-19 pandemic","volume":"2","author":"JSA Ayres","year":"2020","journal-title":"Nat Metab"},{"issue":"11","key":"pone.0304311.ref004","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri2432","article-title":"Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases","volume":"8","author":"DS Schneider","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"pone.0304311.ref005","doi-asserted-by":"crossref","first-page":"e1009225","DOI":"10.1371\/journal.ppat.1009225","article-title":"SARS-CoV-2 tropism, entry, replication, and propagation: considerations for drug discovery and development Co., Inc., Kenilworth, NJ, USA and may own stock or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA","volume":"17","author":"N Murgolo","year":"2021","journal-title":"PLoS Pathog"},{"issue":"18","key":"pone.0304311.ref006","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"China Medical Treatment Expert Group for Covid-19","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0304311.ref007","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s00134-020-06211-2","article-title":"Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study","volume":"46","author":"J Xie","year":"2020","journal-title":"Intensive Care Med"},{"key":"pone.0304311.ref008","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2741\/1915","article-title":"Matrix metalloproteinases (MMPs) in health and disease: an overview","volume":"11","author":"CJ Malemud","year":"2006","journal-title":"Front Biosci"},{"issue":"6","key":"pone.0304311.ref009","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/biology12060843","article-title":"Involvement of matrix metalloproteinases in COVID-19: molecular targets, mechanisms, and insights for therapeutic interventions","volume":"12","author":"R Salom\u00e3o","year":"2023","journal-title":"Biology"},{"issue":"4","key":"pone.0304311.ref010","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/cphy.c160010","article-title":"Modulation of systemic metabolism by MMP-2: from MMP-2 deficiency in mice to MMP-2 deficiency in patients","volume":"6","author":"C Fernandez-Patron","year":"2016","journal-title":"Compr Physiol"},{"key":"pone.0304311.ref011","doi-asserted-by":"crossref","first-page":"112067","DOI":"10.1016\/j.biopha.2021.112067","article-title":"MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients","volume":"142","author":"C DA-M","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"pone.0304311.ref012","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1183\/09031936.00032111","article-title":"Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair","volume":"38","author":"A Davey","year":"2011","journal-title":"Eur Respir J"},{"issue":"4","key":"pone.0304311.ref013","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.humpath.2005.11.023","article-title":"Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury","volume":"37","author":"SE Fligiel","year":"2006","journal-title":"Hum Pathol"},{"key":"pone.0304311.ref014","doi-asserted-by":"crossref","first-page":"118096","DOI":"10.1016\/j.lfs.2020.118096","article-title":"Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis","volume":"257","author":"S Hazra","year":"2020","journal-title":"Life Sci"},{"issue":"3","key":"pone.0304311.ref015","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.jinf.2020.06.061","article-title":"Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure","volume":"81","author":"T Ueland","year":"2020","journal-title":"J Infect"},{"issue":"5","key":"pone.0304311.ref016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"X Cao","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"pone.0304311.ref017","doi-asserted-by":"crossref","first-page":"105205","DOI":"10.1016\/j.micpath.2021.105205","article-title":"Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19","volume":"160","author":"NT Al-Bayatee","year":"2021","journal-title":"Microb Pathog"},{"issue":"7","key":"pone.0304311.ref018","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/microorganisms9071415","article-title":"Antimicrobial peptides and physical activity: a great hope against COVID 19","volume":"9","author":"S Laneri","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"pone.0304311.ref019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/ijmr.ijmr_2798_21","article-title":"Defensins: therapeutic molecules with potential to treat SARS-CoV-2 infection","volume":"155","author":"S Banu","year":"2022","journal-title":"Indian J Med Res"},{"issue":"10","key":"pone.0304311.ref020","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1007\/s11033-022-07572-1","article-title":"Antimicrobial peptides: features, applications and the potential use against covid-19","volume":"49","author":"DM Mabrouk","year":"2022","journal-title":"Mol Biol Rep"},{"key":"pone.0304311.ref021","doi-asserted-by":"crossref","first-page":"104930","DOI":"10.1016\/j.micpath.2021.104930","article-title":"Promising role of defensins peptides as therapeutics to combat against viral infection","volume":"155","author":"SS Solanki","year":"2021","journal-title":"Microb Pathog"},{"issue":"12","key":"pone.0304311.ref022","doi-asserted-by":"crossref","first-page":"e0279270","DOI":"10.1371\/journal.pone.0279270","article-title":"Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases","volume":"17","author":"U Ghulam","year":"2022","journal-title":"PLoS One"},{"key":"pone.0304311.ref023","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.2147\/IDR.S422095","article-title":"Association of interferon lambda 3 and 4 gene SNPs and their expression with COVID-19 disease severity: a cross-sectional study","volume":"16","author":"W Zahid","year":"2023","journal-title":"Infect Drug Res"},{"issue":"6","key":"pone.0304311.ref024","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"TD Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"4","key":"pone.0304311.ref025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"11","key":"pone.0304311.ref026","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/jdv.16774","article-title":"Cutaneous manifestations of SARS-CoV-2 infection: a clinical update","volume":"34","author":"P Gisondi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"pone.0304311.ref027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune determinants of COVID-19 disease presentation and severity","volume":"27","author":"P Brodin","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"pone.0304311.ref028","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/infdis\/jiab288","article-title":"Type I, II, and III interferon signatures correspond to coronavirus disease 2019 severity","volume":"224","author":"M-H SS Kim","year":"2021","journal-title":"J Infect Dis"},{"issue":"7","key":"pone.0304311.ref029","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/v13071246","article-title":"Human defensins inhibit SARS-CoV-2 infection by blocking viral entry","volume":"13","author":"C Xu","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"pone.0304311.ref030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/v11080704","article-title":"Human antimicrobial Peptides as therapeutics for viral infections","volume":"11","author":"A Ahmed","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"pone.0304311.ref031","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/j.gastro.2020.05.015","article-title":"Human intestinal defensin 5 inhibits SARS-CoV-2 invasion by cloaking ACE2","volume":"159","author":"C Wang","year":"2020","journal-title":"Gastroenterology"},{"key":"pone.0304311.ref032","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fimmu.2020.00764","article-title":"Defensins: a double-edged sword in host immunity","volume":"11","author":"D Xu","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"pone.0304311.ref033","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/cbdd.13317","article-title":"Effects of increasing hydrophobicity by N-terminal myristoylation on the antibacterial and hemolytic activities of the C-terminal cationic segments of human-beta-defensins 1-3","volume":"92","author":"V Krishnakumari","year":"2018","journal-title":"Chem Biol Drug Des"},{"issue":"9","key":"pone.0304311.ref034","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.47.9.2804-2809.2003","article-title":"Antimicrobial characterization of human beta-defensin 3 derivatives","volume":"47","author":"DM Hoover","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0304311.ref035","doi-asserted-by":"crossref","first-page":"112067","DOI":"10.1016\/j.biopha.2021.112067","article-title":"MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients. Biomedicine &","volume":"142","author":"D Carolina","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"36","key":"pone.0304311.ref036","doi-asserted-by":"crossref","first-page":"25964","DOI":"10.1074\/jbc.M113.459784","article-title":"Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption","volume":"288","author":"I CJ Herrera","year":"2013","journal-title":"J Biol Chem"},{"key":"pone.0304311.ref037","doi-asserted-by":"crossref","first-page":"593595","DOI":"10.3389\/fimmu.2021.593595","article-title":"Clinical and immunological factors that distinguish COVID-19 from pandemic influenza A (H1N1)","volume":"12","author":"JAJ-AL Chore\u00f1o-Parra","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"pone.0304311.ref038","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/jir.2021.0222","article-title":"Possible role of matrix metalloproteinases and TGF-\u03b2 in COVID-19 Severity and Sequelae","volume":"42","author":"R.M. LAJ Gustavo","year":"2022","journal-title":"J Interferon Cytokine Res"},{"issue":"5","key":"pone.0304311.ref039","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/biom12050604","article-title":"Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8\/MMP-2 axis on immune response through HLA-G shedding and oxidative stress","volume":"12","author":"PV da Silva-Neto","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"pone.0304311.ref040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.PCC.0000192320.87416.1A","article-title":"Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression profiles in tracheal aspirates do not adequately reflect tracheal or lung tissue profiles in neonatal respiratory distress: observations from an animal model","volume":"7","author":"TL Miller","year":"2006","journal-title":"Pediatr Crit Care Med"},{"issue":"9","key":"pone.0304311.ref041","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jmv.23301","article-title":"Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections","volume":"84","author":"KH Brand","year":"2012","journal-title":"J Med Virol"},{"issue":"21","key":"pone.0304311.ref042","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"J Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0304311.ref043","doi-asserted-by":"crossref","first-page":"103255","DOI":"10.1016\/j.ebiom.2021.103255","article-title":"Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity","volume":"65","author":"M Hoffmann","year":"2021","journal-title":"EBioMed"},{"key":"pone.0304311.ref044","first-page":"02.19.481107","article-title":"Identification of a SARS-CoV-2 host metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 and variants of concern Alpha, Delta, and Omicron","author":"M Benlarbi","year":"2022","journal-title":"bioRxiv"},{"key":"pone.0304311.ref045","doi-asserted-by":"crossref","first-page":"750279","DOI":"10.3389\/fimmu.2021.750279","article-title":"Age-related expression of IFN-\u03bb1 versus IFN-I and beta-defensins in the nasopharynx of SARS-CoV-2-infected individuals","volume":"12","author":"C Gilbert","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0304311.ref046","doi-asserted-by":"crossref","first-page":"e04612021","DOI":"10.1590\/0037-8682-0461-2021","article-title":"The seven constitutive respiratory defense barriers against SARS-CoV-2 infection","volume":"54","author":"E Tosta","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"pone.0304311.ref047","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/biology10020095","article-title":"Mucociliary respiratory epithelium integrity in molecular defense and susceptibility to pulmonary viral infections","volume":"10","author":"Adivitiya","year":"2021","journal-title":"Biology"},{"issue":"5","key":"pone.0304311.ref048","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/biom12050604","article-title":"Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8\/MMP-2 axis on immune response through HLA-G shedding and oxidative stress","volume":"12","author":"PV da Silva-Neto","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"pone.0304311.ref049","first-page":"71","article-title":"An improvement of the 2\u02c6 (\u2013delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"X Rao","year":"2013","journal-title":"Biostatistics, Bioinformatic Biomathematic"},{"key":"pone.0304311.ref050","doi-asserted-by":"crossref","DOI":"10.1201\/9780429340512","volume-title":"Principles of biostatistics","author":"M Pagano","year":"2022"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:44:03Z","timestamp":1739904243000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304311"}},"subtitle":[],"editor":[{"given":"Suresh","family":"Yenugu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0304311","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}